On February 8, 2022 Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, reported that management will present and host one-on-one meetings at the following investor conferences during the month of February 2022 (Press release, Affimed, FEB 8, 2022, View Source,conferences%20during%20the%20month%20of [SID1234607853]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

11th SVB Leerink 2022 Global Healthcare Conference (February 14 – 18, 2022)
Date: Wednesday, February 16, 2022
Presentation Time: 11:20 a.m. EST / 17:20 CET
Webcast: View Source
Location: Virtual

Citi’s 2022 Virtual Immuno-Oncology Summit (February 17, 2022)
Date: Thursday, February 17, 2022
Presentation Time: 2:30 p.m. EST / 20:30 CET
Webcast: View Source
Location: Virtual

For more information on the conferences or to schedule a one-on-one meeting with Affimed management, please contact your conference representative or Alex Fudukidis via email at [email protected] or phone at +1 (917) 436-8102.